Hu Guochang, Vasiliauskas Tomas, Salem M Ramez, Rhone Douglas P, Crystal George J
Advocate Illinois Masonic Medical Center, and Department of Anesthesiology, University of Illinois College of Medicine, Chicago 60657-5193, USA.
Anesthesiology. 2003 Mar;98(3):712-8. doi: 10.1097/00000542-200303000-00020.
Volatile anesthetics can precondition the myocardium against functional depression and infarction following ischemia-reperfusion. Neutrophil activation, adherence, and release of superoxide play major roles in reperfusion injury. The authors tested the hypothesis that pretreatment of neutrophils with a volatile anesthetic, i.e., simulated preconditioning, can blunt their ability to cause cardiac dysfunction.
Studies were performed in 60 buffer-perfused and paced isolated rat hearts. Left ventricular developed pressure served as an index of myocardial contractility. Polymorphonuclear neutrophils and/or drugs were added to coronary perfusate for 10 min, followed by 30 min of recovery. Platelet-activating factor was used to stimulate neutrophils. Pretreatment of neutrophils consisted of incubation with 1.0 minimum alveolar concentration (MAC) isoflurane or sevoflurane for 15 min, followed by washout. Additional studies were performed with 0.25 MAC isoflurane. Effects of superoxide dismutase were compared to those of volatile anesthetics. Superoxide production was measured by spectrophotometry. Neutrophil adherence to coronary vascular endothelium was estimated from the difference between neutrophils administered and recovered in coronary venous effluent.
Activated neutrophils caused marked, persistent reduction (> 50%) in left ventricular developed pressure. Isoflurane and sevoflurane at 1.0 MAC and superoxide dismutase abolished this effect. Isoflurane and sevoflurane reduced superoxide production of activated neutrophils by 29% and 33%, respectively, and completely prevented the platelet-activating factor-induced increases in neutrophil adherence. Isoflurane at 0.25 MAC blunted, but did not abolish, the neutrophil-induced decreases in left ventricular developed pressure.
Neutrophils pretreated with 1.0 MAC isoflurane or sevoflurane lost their ability to cause cardiac dysfunction, while those pretreated with a concentration of isoflurane as low as 0.25 MAC were partially inhibited. This action of the volatile anesthetics was associated with reductions in superoxide production and neutrophil adherence to the coronary vascular endothelium. Our findings suggest that inhibitory actions on neutrophil activation and neutrophil-endothelium interaction may contribute to the preconditioning effects of volatile anesthetics observed in vivo during myocardial ischemia-reperfusion.
挥发性麻醉药可使心肌对缺血再灌注后的功能抑制和梗死产生预处理作用。中性粒细胞的激活、黏附以及超氧化物的释放,在再灌注损伤中起主要作用。作者检验了以下假设:用挥发性麻醉药预处理中性粒细胞(即模拟预处理),可减弱其导致心脏功能障碍的能力。
对60个经缓冲液灌注并起搏的离体大鼠心脏进行研究。左心室舒张末压作为心肌收缩力的指标。将多形核中性粒细胞和/或药物加入冠状动脉灌注液中10分钟,随后恢复30分钟。用血小板活化因子刺激中性粒细胞。中性粒细胞的预处理包括用1.0最低肺泡浓度(MAC)的异氟烷或七氟烷孵育15分钟,然后冲洗。还用0.25 MAC的异氟烷进行了额外研究。将超氧化物歧化酶的作用与挥发性麻醉药的作用进行比较。通过分光光度法测量超氧化物的产生。根据冠状动脉流出液中给予和回收的中性粒细胞之间的差异,估算中性粒细胞对冠状动脉血管内皮的黏附情况。
活化的中性粒细胞导致左心室舒张末压显著、持续降低(>50%)。1.0 MAC的异氟烷和七氟烷以及超氧化物歧化酶消除了这种作用。异氟烷和七氟烷分别使活化中性粒细胞的超氧化物产生减少29%和33%,并完全阻止了血小板活化因子诱导的中性粒细胞黏附增加。0.25 MAC的异氟烷减弱但未消除中性粒细胞诱导的左心室舒张末压降低。
用1.0 MAC异氟烷或七氟烷预处理的中性粒细胞失去了导致心脏功能障碍的能力,而用低至0.25 MAC浓度的异氟烷预处理的中性粒细胞则受到部分抑制。挥发性麻醉药的这种作用与超氧化物产生减少以及中性粒细胞对冠状动脉血管内皮的黏附减少有关。我们的研究结果表明,对中性粒细胞激活和中性粒细胞 - 内皮细胞相互作用的抑制作用,可能有助于在心肌缺血再灌注期间在体内观察到的挥发性麻醉药的预处理作用。